Physician

Benjamin Jay Workman, M.D.

According to 2025 Medicare claims, Benjamin Workman, M.D. (NPI: 1568751931) practices dermatology in the Bay City, MI market, with the plurality of this provider's patient population coming from Bay, MI. This provider's primary affiliated billing organization is BRENT M BOYCE MD PC (NPI: 1982736054; TIN: 20-0060755) and primary practice location at 48706-2554.

Workman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,140 traditional Medicare patients, billed 4,106 HCPCS/CPT codes, and received $202,958 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 2,052 prescription claims across 795 beneficiaries totaling $3,681,860 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 263 records totaling $59,748. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $50,851 to $202,958. Similarly, Part D prescription costs have moved sharply higher in recent years, from $47,152 to $3,681,860. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$101K$203K2015 Medicare payment: $50,851 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $143,600 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $150,225 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $148,880 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $157,618 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $135,788 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $171,053 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $153,230 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $175,814 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $202,958 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153811,147$50,851
20169133,254$143,600
20179903,726$150,225
20181,0223,885$148,880
20191,0793,864$157,618
20209543,556$135,788
20211,0654,303$171,053
20221,1363,760$153,230
20231,1053,712$175,814
20241,1404,106$202,958

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.8M$3.7M2015 Drug cost: $47,152 (USD; Tot_Drug_Cst)2016 Drug cost: $448,764 (USD; Tot_Drug_Cst)2017 Drug cost: $575,463 (USD; Tot_Drug_Cst)2018 Drug cost: $696,696 (USD; Tot_Drug_Cst)2019 Drug cost: $779,622 (USD; Tot_Drug_Cst)2020 Drug cost: $1,395,778 (USD; Tot_Drug_Cst)2021 Drug cost: $1,750,607 (USD; Tot_Drug_Cst)2022 Drug cost: $2,156,285 (USD; Tot_Drug_Cst)2023 Drug cost: $3,135,062 (USD; Tot_Drug_Cst)2024 Drug cost: $3,681,860 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015183385$47,152
2016408975$448,764
20175091,288$575,463
20185181,380$696,696
20195591,292$779,622
20205671,412$1,395,778
20215881,637$1,750,607
20226421,659$2,156,285
20237171,943$3,135,062
20247952,052$3,681,860

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths178193$76
11102Biopsy of related skin growth, first growth165180$60
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more653778$58
17000Destruction of precancer skin growth, 1 growth455525$39
17003Destruction of precancer skin growth, 2-14 growths2981,177$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa594,592$1,205,411
Dupixent PenDupilumab1534,284$627,704
Humira(Cf) PenAdalimumab461,568$589,873
TremfyaGuselkumab15840$200,949
Dupixent SyringeDupilumab32980$126,870

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.263$59,748Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Benjamin Jay Workman, M.D.?

Tedicare shows public-source Medicare data for Benjamin Jay Workman, M.D. (NPI 1568751931), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benjamin Jay Workman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Benjamin Jay Workman, M.D.?

Benjamin Jay Workman, M.D. is linked to BRENT M BOYCE MD PC (billing NPI 1982736054) in the available physician profile data.

Does Benjamin Jay Workman, M.D. have Open Payments data?

Benjamin Jay Workman, M.D. has 263 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.